Stay updated with breaking news from Life Sciences Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ENDRA Life Sciences Inc. (NASDAQ:NDRA – Get Free Report) was the target of a significant growth in short interest during the month of May. As of May 15th, there was short interest totalling 104,700 shares, a growth of 2,517.5% from the April 30th total of 4,000 shares. Based on an average daily volume of 184,100 […]
SEATTLE and VANCOUVER, British Columbia, May 29, 2024 -- Achieve Life Sciences, Inc. , or Achieve, a late-stage pharmaceutical company committed to the global development and commercialization of...
Increases clarity for ENDRA on regulatory path forward for TAEUS ...
Achieve Life Sciences, Inc. (NASDAQ:ACHV – Free Report) – Equities researchers at Zacks Small Cap issued their Q2 2024 earnings per share estimates for shares of Achieve Life Sciences in a note issued to investors on Monday, May 13th. Zacks Small Cap analyst J. Vandermosten anticipates that the biopharmaceutical company will earn ($0.21) per share […]
Jonestrading assumed coverage on shares of Achieve Life Sciences (NASDAQ:ACHV – Free Report) in a research report report published on Wednesday morning, Benzinga reports. The firm issued a buy rating and a $20.00 price objective on the biopharmaceutical company’s stock. Several other analysts have also issued reports on ACHV. Lake Street Capital cut their target […]